Yilmaz A - Search Results

1

Changes in Cerebrospinal Fluid Proteins across the Spectrum of Untreated and Treated Chronic HIV-1 Infection.

Hu Z, Cinque P, Dravid A, Hagberg L, Yilmaz A, Zetterberg H, Fuchs D, Gostner J, Blennow K, Spudich SS, Kincer L, Zhou S, Joseph S, Swanstrom R, Price RW, Gisslén M. Hu Z, et al. Among authors: yilmaz a. bioRxiv [Preprint]. 2024 May 5:2024.05.03.592451. doi: 10.1101/2024.05.03.592451. bioRxiv. 2024. Update in: PLoS Pathog. 2024 Sep 24;20(9):e1012470. doi: 10.1371/journal.ppat.1012470 PMID: 38746436 Free PMC article. Updated. Preprint.

2

Cerebrospinal fluid and plasma HIV-1 RNA levels and lopinavir concentrations following lopinavir/ritonavir regimen.

Yilmaz A, Ståhle L, Hagberg L, Svennerholm B, Fuchs D, Gisslén M. Yilmaz A, et al. Scand J Infect Dis. 2004;36(11-12):823-8. doi: 10.1080/00365540410025320. Scand J Infect Dis. 2004. PMID: 15764168 Clinical Trial.

3

Cerebrospinal fluid HIV-1 RNA, intrathecal immunoactivation, and drug concentrations after treatment with a combination of saquinavir, nelfinavir, and two nucleoside analogues: the M61022 study.

Yilmaz A, Fuchs D, Hagberg L, Nillroth U, Ståhle L, Svensson JO, Gisslén M. Yilmaz A, et al. BMC Infect Dis. 2006 Mar 27;6:63. doi: 10.1186/1471-2334-6-63. BMC Infect Dis. 2006. PMID: 16566834 Free PMC article.

4

Cerebrospinal fluid viral loads reach less than 2 copies/ml in HIV-1-infected patients with effective antiretroviral therapy.

Yilmaz A, Svennerholm B, Hagberg L, Gisslén M. Yilmaz A, et al. Antivir Ther. 2006;11(7):833-7. Antivir Ther. 2006. PMID: 17302245

5

Persistent intrathecal immune activation in HIV-1-infected individuals on antiretroviral therapy.

Yilmaz A, Price RW, Spudich S, Fuchs D, Hagberg L, Gisslén M. Yilmaz A, et al. J Acquir Immune Defic Syndr. 2008 Feb 1;47(2):168-73. doi: 10.1097/QAI.0b013e31815ace97. J Acquir Immune Defic Syndr. 2008. PMID: 17971711 Free PMC article.

6

Darunavir concentrations in cerebrospinal fluid and blood in HIV-1-infected individuals.

Yilmaz A, Izadkhashti A, Price RW, Mallon PW, De Meulder M, Timmerman P, Gisslén M. Yilmaz A, et al. AIDS Res Hum Retroviruses. 2009 Apr;25(4):457-61. doi: 10.1089/aid.2008.0216. AIDS Res Hum Retroviruses. 2009. PMID: 19320601 Free PMC article.

7

Raltegravir cerebrospinal fluid concentrations in HIV-1 infection.

Yilmaz A, Gisslén M, Spudich S, Lee E, Jayewardene A, Aweeka F, Price RW. Yilmaz A, et al. PLoS One. 2009 Sep 1;4(9):e6877. doi: 10.1371/journal.pone.0006877. PLoS One. 2009. PMID: 19721718 Free PMC article.

8

Cerebrospinal fluid maraviroc concentrations in HIV-1 infected patients.

Yilmaz A, Watson V, Else L, Gisslèn M. Yilmaz A, et al. AIDS. 2009 Nov 27;23(18):2537-40. doi: 10.1097/QAD.0b013e328333ae0e. AIDS. 2009. PMID: 19855252

9

Treatment intensification has no effect on the HIV-1 central nervous system infection in patients on suppressive antiretroviral therapy.

Yilmaz A, Verhofstede C, D'Avolio A, Watson V, Hagberg L, Fuchs D, Svennerholm B, Gisslén M. Yilmaz A, et al. J Acquir Immune Defic Syndr. 2010 Dec 15;55(5):590-6. doi: 10.1097/QAI.0b013e3181f5b3d1. J Acquir Immune Defic Syndr. 2010. PMID: 20847699 Clinical Trial.

10

Antiretroviral drug treatment of CNS HIV-1 infection.

Yilmaz A, Price RW, Gisslén M. Yilmaz A, et al. J Antimicrob Chemother. 2012 Feb;67(2):299-311. doi: 10.1093/jac/dkr492. Epub 2011 Dec 8. J Antimicrob Chemother. 2012. PMID: 22160207 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,468 results

Search Page

Filters